0001209191-23-001354.txt : 20230104 0001209191-23-001354.hdr.sgml : 20230104 20230104183500 ACCESSION NUMBER: 0001209191-23-001354 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221208 FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chung Christine CENTRAL INDEX KEY: 0001775295 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 23508897 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-12-08 2022-12-09 0 0000921299 FIBROGEN INC FGEN 0001775295 Chung Christine C/O FIBROGEN, INC. 409 ILLINOIS ST. SAN FRANCISCO CA 94158 0 1 0 0 SVP, China Operations Common Stock 2022-12-08 4 S 0 2595 15.79 D 234873 D Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. This Form 4/A is being filed to correct the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units. /s/ Cecelia Monoarfa-Taime, Attorney-in-fact 2023-01-04